In vitro and in vivo antitumor activity of a novel nucleoside, 4'-thio-2'-deoxy-2'-methylidenecytidine. 1996

S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
Department of Experimental Therapeutics, Kanazawa University, Japan.

The in vitro and in vivo antitumor activity of a novel nucleoside, 4'-thio-2'-deoxy-2'-methylidenecytidine (4'-thio-DMDC), was examined. 4'-Thio-DMDC inhibited the growth of various cell lines established from human solid cancers, particularly the growth of lung and bladder carcinomas and melanomas. 4'-Thio-DMDC exhibited potent antitumor activity against subcutaneously implanted murine sarcoma S-180 and human fibrosarcoma HT-1080 xenografts. It was shown that 4'-thio-DMDC suppressed cell growth by inhibiting cellular DNA synthesis, and phosphorylation of the 5'-position of its deoxyribose by deoxycytidine kinase was needed for its antitumor activity. 4'-Thio-DMDC is a poor substrate for cytidine deaminase, thus it is a promising agent for the treatment of malignant solid tumors because it will not be converted into its inactive uridine form.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D003564 Cytidine Deaminase An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5. Cytidine Aminohydrolase,Aminohydrolase, Cytidine,Deaminase, Cytidine
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D013872 Thionucleosides Nucleosides in which the base moiety is substituted with one or more sulfur atoms.

Related Publications

S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
May 1991, Cancer research,
S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
September 1991, Journal of medicinal chemistry,
S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
June 1988, Journal of medicinal chemistry,
S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
June 2010, Chemical biology & drug design,
S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
December 2021, Clinical cancer research : an official journal of the American Association for Cancer Research,
S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
October 1999, Cancer letters,
S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
January 1999, Nucleosides & nucleotides,
S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
January 1996, Journal of medicinal chemistry,
S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
August 1991, Journal of medicinal chemistry,
S Miura, and M Tanaka, and Y Yoshimura, and H Satoh, and S Sakata, and H Machida, and A Matsuda, and T Sasaki
March 1999, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!